Saranac Partners Ltd

Position in AZN — Astrazeneca PLC

CIK 2098745 LONDON, X0

Position in AZN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$857,461

-$241,251 QoQ

Shares Held

4,522

-18.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.29%

of 13F equity value

Holder Rank

#702

of 1,459 holders

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Saranac Partners Ltd holds $13,142,776 across 6 Drug Manufacturers - General names. AZN ranks #2 (6.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	41,086	$10,338,881
2	AZN	Astrazeneca PLC This page	4,522	$857,461
3	LLY	ELI LILLY & Co	487	$584,122
4	NVO	Novo Nordisk A S	11,090	$531,654
5	BMY	Bristol Myers Squibb Co	7,311	$421,259
6	JNJ	Johnson & Johnson	1,612	$409,399

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$857,461	4,522	-18.8%	Shares	Sole	2026-08-13
2026-03-31	$1,098,712	5,571	-4.2%	Shares	Sole	2026-05-15
2025-09-30	$446,279	5,817	—	Shares	Sole	2025-12-05
No filing history on record for this holder in this stock.